Momenta Pharmaceuticals (NASDAQ:MNTA) reported Q1 2018 earnings this Morning, coming in at ($0.63) per share, missing Wall Street’s estimates of ($0.48) per Share. Revenue for the quarter came in at $4.85 million beating analyst estimates of $15.63 million Recent Insider Trading for Momenta Pharmaceuticals (NASDAQ:MNTA)
- On 5/2/2018 Craig A Wheeler, CEO, sold 80,770 with an average share price of $20.86 per share and the total transaction amounting to $1,684,862.20.
- On 4/26/2018 Elizabeth Stoner, Director, sold 3,857 with an average share price of $20.00 per share and the total transaction amounting to $77,140.00.
- On 4/19/2018 Craig A Wheeler, CEO, sold 5,896 with an average share price of $21.00 per share and the total transaction amounting to $123,816.00.
- On 4/19/2018 Young Kwon, SVP, sold 15,089 with an average share price of $20.90 per share and the total transaction amounting to $315,360.10.
- On 4/12/2018 Elizabeth Stoner, Director, sold 7,714 with an average share price of $20.00 per share and the total transaction amounting to $154,280.00.
- On 4/10/2018 Craig A. Wheeler, CEO, sold 43,334 with an average share price of $19.00 per share and the total transaction amounting to $823,346.00.
Dividend History for Momenta Pharmaceuticals (NASDAQ:MNTA)
Recent Trading for Momenta Pharmaceuticals (NASDAQ:MNTA) Shares of Momenta Pharmaceuticals closed the previous trading session at 17.35 down -4.05 18.93% with 18.25 shares trading hands.